GabriellePage-WilsonMD
Endocrinology • New York, NYDiabetes, Gonad Disorders & Reproductive, Obesity, Pituitary Disorders & Neuroendocrinology
Associate Professor of Medicine
Dr. Page-Wilson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Atria
36 E 57TH Street 5TH FL
New York, NY 10022Phone+1 212-600-2000Fax+1 212-540-0855
Summary
- Dr. Gabrielle Page-Wilson is an endocrinologist in New York, NY and is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Harvard Medical School and has been in practice 11 years. She specializes in complex hormonal disorders including pituitary disorders, disorders of reproduction in both men and women, menopause, neuroendocrinology and obesity. She has extensive clinical research experience and has served as a Principal Investigator for NIH funded and sponsored clinical trials. She has over 25 publications and speaks nationally on diverse endocrine topics.
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 2008
Harvard Medical SchoolClass of 2005
New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism
Certifications & Licensure
FL State Medical License 2021 - 2026
PA State Medical License 2024 - 2026
CO State Medical License 2024 - 2025
CT State Medical License 2022 - 2025
NJ State Medical License 2022 - 2025
NY State Medical License 2008 - 2025- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole Start of enrollment: 2016 Sep 16
- Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease Start of enrollment: 2018 Jul 16
Publications & Presentations
PubMed
- 7 citationsGenome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.Andrew L Lin, Vasilisa A Rudneva, Allison L Richards, Yanming Zhang, Hyung Jun Woo
Acta Neuropathologica. 2024-05-17 - 1 citationsRopinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability.Liam J Heneghan, Amanda Tsang, Cara Dimino, Alexander G Khandji, Sunil K Panigrahi
The Journal of Clinical Endocrinology and Metabolism. 2024-01-18 - 4 citationsThe treatment of aggressive prolactinomas with everolimus.Andrew L Lin, Eliza B Geer, Nupur Lala, Gabrielle Page-Wilson, Rajiv Magge
Pituitary. 2023-08-01
Press Mentions
Treatment of Hyperprolactinemia with the Non-Ergoline Dopamine Agonist RopiniroleJanuary 31st, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
